Schedule 13D ownership disclosure
LUMOS PHARMA INC
Security class unavailable · CUSIP: 55028X109
Event date: 2023-05-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 643,338
- Percent of class
- 7.8700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001062993-23-012149
- Form type
- SC 13D
- Filer
- Farb Daniel Stuart
- CIK
- CIK 1776353
- Filed
- May 25, 2023
- Reporting period
- May 24, 2023
- Description
- Schedule 13D beneficial ownership